Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients-Reference-Cited by-同舟云学术

Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients

Published:2021-03 Issue: Volume:156 Page:153-159
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Saha Animesh,Beasley Matthew^ORCID,Hatton Nathaniel^ORCID,Dickinson Peter,Franks Kevin,Clarke Katy,Jain Pooja^ORCID,Teo Mark,Murray Patrick,Lilley John

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference41 articles.

1. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2014

2. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening;Wood;Thorac Surg Clin,2015

3. Lung cancer diagnosis and management 2019 [Available from: https://www.nice.org.uk/guidance/ng122/chapter/Recommendations#treatment.

4. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

5. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?;Mirimanoff;Chin Clin Oncol,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on developing a predictive model for radiation pneumonitis risk based on radiomics and multiparameters;2024-01-30

2. Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receiving radiotherapy: a retrospective multi-center radiogenomics study;BMC Cancer;2024-01-15

3. Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers;Clinical Lung Cancer;2023-12

4. Analysis of clinical and physical dosimetric factors that determine the outcome of severe acute radiation pneumonitis in lung cancer patients;Radiation Oncology;2023-08-29

5. Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy;Radiotherapy and Oncology;2023-06